Biogen Idec
Latest Biogen Idec News
-
Wall Street Risks Push Investors Toward Faith-Based Funds4.8 percent (the fund has only been operating since December 2009.) Top Holdings: US Bancorp, M&T Bank, Biogen Idec Investing Criteria: The firm offers funds that reflect five Christian denominations: Baptist, Catholic, Christian
-
Type 1 Diabetes May Have a New Foe
Health, the Juvenile Diabetes Research Foundation International and the American Diabetes Association. Genentech and Biogen Idec , which make rituximab, provided the medication for the trial. More information There's more on type 1 diabetes
-
Promising Results for Experimental Lymphoma Vaccineeach kind of lymphoma," he said. The study was supported by Biovest International. The researchers reported financial links with Accentia Biopharmaceuticals, Biovest International, Antigenics, Biogen Idec , Genentech and Xeme Biopharma.
-
CT Lung Cancer Screening Leaves a Trail of False Positives
Institute. Croswell did not report any conflicts. Bach has reported financial links with Genentech, Wyeth, Abraxis, Biogen - Idec , and Johnson and Johnson. Edelman has reported financial links with Bristol-Myers Squibb, Cyclacel, Eli Lilly
-
Leukemia Risk From MS Drug May Be Up
of MS disability, whereas the scores for the interferon-only group decreased slightly. The study was funded by Biogen - Idec , which makes Avonex. More information The National Multiple Sclerosis Society has more on MS . SOURCES: Vittorio
-
Drug Combo May Relieve MS Symptoms
improvement on a test of MS disability, while those in the placebo/interferon group showed a slight decline. The Biogen Idec -supported study also found that MS-related brain lesions stayed the same size or shrank in the steroid/interferon
News
-
Tysabri May Treat Myelin Sheath Damage From MS
regenerate and stabilize damage done to the myelin sheath in people with multiple sclerosis (MS), a study from drug makers Biogen Idec and Elan Corp shows. MS is nervous system disease that affects the brain and spinal cord. Symptoms experienced by
-
Look for a list of industry leaders in 10-K reports
also emerge as competitors. These include Genzyme, Amgen, Cephalon, Shire Pharmaceuticals, BioMarin, Celgene, Biogen Idec , and Titan Pharmaceuticals/Schering AG. Finally, we also expect to compete with smaller biotechnology companies
-
Health Highlights: Oct. 19, 2008
The drug was obtained through the Mayo Clinic, which consulted with the U.S. Food and Drug Administration. Biogen Idec Inc , which makes Tysabri, didn't approve Baron's use of the drug because the regulatory risks of giving him special
-
Health Highlights: Oct. 18, 2008
The drug was obtained through the Mayo Clinic, which consulted with the U.S. Food and Drug Administration. Biogen Idec Inc , which makes Tysabri, didn't approve Baron's use of the drug because the regulatory risks of giving him special
-
Health Highlights: Oct. 17, 2008
The drug was obtained through the Mayo Clinic, which consulted with the U.S. Food and Drug Administration. Biogen Idec Inc , which makes Tysabri, didn't approve Baron's use of the drug because the regulatory risks of giving him special
-
Health Highlights: Sept. 14, 2008
developed PML, according to information on the FDA Web site. Rituxan is marketed in the United States by Genentch and Biogen Idec . Genentech sent a letter about the woman's death to doctors earlier this month and a company spokeswoman pointed
-
Health Highlights: Sept. 13, 2008
developed PML, according to information on the FDA Web site. Rituxan is marketed in the United States by Genentch and Biogen Idec . Genentech sent a letter about the woman's death to doctors earlier this month and a company spokeswoman pointed
